MDGL Stock Triples After Knocking NASH Study Out Of The Park
Madrigal Pharmaceuticals (MDGL) scored a win in a particularly tricky field on Monday after its final-phase study hit both its goals, sending MDGL stock into the stratosphere.
X
Shares of Madrigal soared a whopping 268.1% on…